Cargando…

Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT

PURPOSE: The specific binding ratio (SBR) of (123)I-FP-CIT (FP-CIT) in the putamen decreases with age by about 5% per decade and most likely is about 10% higher in females. However, the clinical utility of age and sex correction of the SBR is still a matter of debate. This study tested the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitz-Steinkrüger, Helen, Lange, Catharina, Apostolova, Ivayla, Mathies, Franziska L., Frings, Lars, Klutmann, Susanne, Hellwig, Sabine, Meyer, Philipp T., Buchert, Ralph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113204/ https://www.ncbi.nlm.nih.gov/pubmed/33130960 http://dx.doi.org/10.1007/s00259-020-05085-2

Ejemplares similares

Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
por: Schiebler, Tassilo, et al.
Publicado: (2023)

Stereotactical normalization with multiple templates representative of normal and Parkinson-typical reduction of striatal uptake improves the discriminative power of automatic semi-quantitative analysis in dopamine transporter SPECT
por: Apostolova, Ivayla, et al.
Publicado: (2023)

Multiple-pinhole collimators improve intra- and between-rater agreement and the certainty of the visual interpretation in dopamine transporter SPECT
por: Mathies, Franziska, et al.
Publicado: (2022)

Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting
por: Buchert, Ralph, et al.
Publicado: (2019)

Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI
por: Nazari, Mahmood, et al.
Publicado: (2021)

Explainable AI to improve acceptance of convolutional neural networks for automatic classification of dopamine transporter SPECT in the diagnosis of clinically uncertain parkinsonian syndromes
por: Nazari, Mahmood, et al.
Publicado: (2021)

Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [(18)F]FDG PET
por: Hellwig, Sabine, et al.
Publicado: (2018)

Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
por: Thiele, Felix, et al.
Publicado: (2023)

Evaluation of [(68) Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria
por: Koehler, Daniel, et al.
Publicado: (2022)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

More extensive hypometabolism and higher mortality risk in patients with right- than left-predominant neurodegeneration of the anterior temporal lobe
por: Frings, Lars, et al.
Publicado: (2023)

Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT
por: Pitkonen, Miia, et al.
Publicado: (2012)

Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT
por: Neill, Matthew, et al.
Publicado: (2021)

Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients
por: Katthagen, Teresa, et al.
Publicado: (2020)

Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
por: Jakobson Mo, Susanna, et al.
Publicado: (2013)

Dopamine Transporter Imaging Using (99m)Tc-TRODAT-1 SPECT in Parkinson’s Disease
por: Bor-Seng-Shu, Edson, et al.
Publicado: (2014)

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
por: Meles, Sanne K., et al.
Publicado: (2017)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC
por: Apostolova, Ivayla, et al.
Publicado: (2014)

O5.1. STRIATAL DOPAMINE AND REDUCED REWARD PREDICTION ERROR SIGNALING IN UNMEDICATED SCHIZOPHRENIA PATIENTS
por: Katthagen, Teresa, et al.
Publicado: (2020)

Evaluation of dopamine transporter density in healthy Brazilians using Tc-99m TRODAT-1 SPECT
por: dos Reis, Marilia Alves, et al.
Publicado: (2021)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Evaluation of Iterative Reconstruction Method and Attenuation Correction in Brain Dopamine Transporter SPECT Using an Anthropomorphic Striatal Phantom
por: Maebatake, Akira, et al.
Publicado: (2016)

Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools
por: Morbelli, Silvia, et al.
Publicado: (2020)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
por: Thomsen, Gerda, et al.
Publicado: (2013)

The Feasibility of Using CT-Guided ROI for Semiquantifying Striatal Dopamine Transporter Availability in a Hybrid SPECT/CT System
por: Hsu, Chien-Chin, et al.
Publicado: (2014)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Consolidation of a Learned Skill Correlates with Dopamine SPECT Uptake in Early Parkinson's Disease
por: Nicastro, Nicolas, et al.
Publicado: (2018)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Differences of Various Region-of-Interest Methods for Measuring Dopamine Transporter Availability Using (99m) T c-TRODAT-1 SPECT
por: Yin, Tang-Kai, et al.
Publicado: (2014)

Dopamine Transporter maging with Tc-99m TRODAT-1 SPECT in Parkinson’s isease and its orrelation with linical isease everity
por: Patel, Asra, et al.
Publicado: (2019)

Faster Acquisition for Dopamine Transporter Imaging Using Swiftscan Step and Shoot Continuous SPECT Without Impairing Visual and Semiquantitative Analysis
por: Bailly, Matthieu, et al.
Publicado: (2020)

Using Artificial Neural Network to Discriminate Parkinson’s Disease from Other Parkinsonisms by Focusing on Putamen of Dopamine Transporter SPECT Images
por: Chien, Chung-Yao, et al.
Publicado: (2020)

Experimental evaluation of absolute quantification in (99m)Tc‐TRODAT‐1 SPECT/CT brain dopamine transporter (DAT) studies
por: Zainudin, Norasma Amira, et al.
Publicado: (2022)

Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake
por: Bae, Yun Jung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kc2rjc0q0dk0nhicotcvm7cpkj